Arch. Dis. Child

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Paoli, A G
Right arrow Articles by Davis, P G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Paoli, A G
Right arrow Articles by Davis, P G
Archives of Disease in Childhood Fetal and Neonatal Edition 2003;88:F168
© 2003 Archives of Disease in Childhood Fetal and Neonatal Edition


REVIEW

Nasal CPAP for neonates: what do we know in 2003?

A G De Paoli, C Morley, P G Davis

Neonatal Intensive Care Unit, Royal Women’s Hospital, Melbourne, Victoria 3053, Australia

Correspondence to:
Correspondence to:
Professor C Morley, Neonatal Intensive Care Unit, Royal Women’s Hospital, Melbourne, Victoria 3053, Australia;
colin.morley{at}wch.org.au


ABSTRACT
Despite the acknowledged clinical usefulness of nasal CPAP, uncertainties regarding aspects of its application remain. Clinical indications for the application of nasal CPAP vary greatly between institutions. Furthermore, defining the optimal nasal CPAP system is complicated by the multiplicity of nasal CPAP devices and techniques available to the clinician. This review aims to identify what we know about nasal CPAP and what important questions remain.


Keywords: CPAP; infant; neonate

Abbreviations: CLD, chronic lung disease; CPAP, continuous positive airway pressure; ET, endotracheal; IFD, infant flow driver; NIPPV, nasal intermittent positive pressure ventilation; RDS, respiratory distress syndrome




This article has been cited by other articles:


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
BAPM/NNS: Cardiovascular and Respiratory
Arch. Dis. Child. Fetal Neonatal Ed., June 1, 2008; 93(Suppl_1): Fa25 - Fa31.
[Full Text] [PDF]


Home page
PediatricsHome page
P. G. Murray and M. J. Stewart
Use of Nasal Continuous Positive Airway Pressure During Retrieval of Neonates With Acute Respiratory Distress
Pediatrics, April 1, 2008; 121(4): e754 - e758.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
L. S Owen, C. J Morley, and P. G Davis
Neonatal nasal intermittent positive pressure ventilation: what do we know in 2007?
Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2007; 92(5): F414 - F418.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
B. T. Bloom, R. H. Clark, and for the Infasurf Survanta Clinical Trial Group
Comparison of Infasurf (Calfactant) and Survanta (Beractant) in the Prevention and Treatment of Respiratory Distress Syndrome
Pediatrics, August 1, 2005; 116(2): 392 - 399.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
L Bowe and P Clarke
Current use of nasal continuous positive airways pressure in neonates
Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2005; 90(1): F92 - F93.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health